Harm reduction and hepatitis C: on the ethics and politics of prevention and treatment

保存先:

書誌詳細
第一著者:	Fraser, S.
その他の著者:	Moore, D.
フォーマット:	図書
言語:	スペイン語英語
主題:	Acción contra las drogodependencias Drogodependencias Enfermos Hepatitis Reducción de daños Tendencias Adicciones Documental
オンライン･アクセス:	DOI Path
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料: Harm reduction and hepatitis C: on the ethics and politics of prevention and treatment

Quick Look
HEPATITIS C TRANSMISSION AND INJECTING DRUG USE: HARM REDUCTION RESPONSES
Quick Look
HARM REDUCTION, HEPATITIS C AND OPIOID PHARMACOTHERAPY: AN OPPORTUNITY FOR INTEGRATED HEPATITIS C VIRUS. SPECIFIC HARM REDUCTION
Quick Look
THE POLITICS OF HARM REDUCTION IN FRANCE
Quick Look
VALUES AND ETHICS IN HARM REDUCTION
Quick Look
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
Quick Look
Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
Quick Look
HEPATITIS C VIRUS INFECTION AMONG INJECTING DRUG USERS: HAS HARM REDUCTION WORKED?
Quick Look
HEPATITIS C PREVENTION AND CARE FOR INJECTING DRUG USERS
Quick Look
Low incidence of hepatitis C virus among prisoners in Scotland
Quick Look
INCREASING TRENDS TOWARDS THE REDUCTION OF DRUG-RELATED HARM THROUGHOUT ASIA
Quick Look
STRENGTHENING DRUG POLICY AND PRACTICE THROUGH ETHICS ENGAGEMENT: AN OLD CHALLENGE FOR A NEW HARM REDUCTION
Quick Look
THE ROLE OF THE POLICE IN HARM REDUCTION. EN: THE REDUCTION OF DRUG-RELATED HARM
Quick Look
HEPATITIS C AND ITS RISK MANAGEMENT AMONG DRUG INJECTORS IN LONDON: RENEWING HARM REDUCTION IN THE CONTEXT OF UNCERTAINTY
Quick Look
ENGAGEMENT, RECIPROCITY AND ADVOCACY: ETHICAL HARM REDUCTION PRACTICE IN RESEARCH WITH INJECTIN DRUG USERS
Quick Look
HEPATITIS C PREVENTION AND TREATMENT FOR SUBSTANCE USERS IN THE UNITED STATES: ACKNOWLEDGING THE ELEPHANT IN THE LIVING ROOM
Quick Look
Peer-delivered mail-order self-collection and linkage to treatment for hepatitis C virus infection among users of a harm reduction service in Denmark
Quick Look
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study
Quick Look
Hepatitis C among people who use drugs: Key messages from practitioners
Quick Look
HEPATITIS B VACCINATION: AN UNMET CHALLENGE IN THE ERA OF HARM REDUCTION PROGRAMS
Quick Look
THE IMPACT OF HARM REDUCTION DRUG POLICY ON AIDS PREVENTION IN AMSTERDAM. EN: THE REDUCTION OF DRUG-RELATED HARM
Quick Look
IMPACT OF A HARM-REDUCTION POLICY ON HIV AND HEPATITIS C VIRUS TRANSMISSION AMONG DRUG USERS: RECENT FRENCH DATA-THE ANRS-COQUELICOT STUDY
Quick Look
THE ETHICS OF HARM REDUCTION
Quick Look
CASTING LIGHT ON HARM REDUCTION: INTRODUCING TWO INSTRUMENTS FOR ANALYSING CONTRADICTIONS BETWEEN HARM REDUCTION AND NON HARM REDUCTION
Quick Look
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings